These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8434822)

  • 1. Kinetics of immobilized heparinase in human blood.
    Freed LE; Vunjak-Novakovic GV; Bernstein H; Cooney CL; Langer R
    Ann Biomed Eng; 1993; 21(1):67-76. PubMed ID: 8434822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioreactor based on suspended particles of immobilized enzyme.
    Freed LE; Vunjak-Novakovic GV; Drinker PA; Langer R
    Ann Biomed Eng; 1993; 21(1):57-65. PubMed ID: 8434821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An immobilized microbial heparinase for blood deheparinization.
    Linhardt RJ; Cooney CL; Tapper D; Zannetos CA; Larsen AK; Langer R
    Appl Biochem Biotechnol; 1984 Feb; 9(1):41-55. PubMed ID: 6476820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ex vivo model of an immobilized-enzyme reactor.
    Bernstein H; Langer R
    Proc Natl Acad Sci U S A; 1988 Nov; 85(22):8751-5. PubMed ID: 3186758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of a whole blood fluidized bed Taylor-Couette flow device for enzymatic heparin neutralization.
    Ameer GA; Harmon W; Sasisekharan R; Langer R
    Biotechnol Bioeng; 1999 Mar; 62(5):602-8. PubMed ID: 10099569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immobilized heparinase: In vitro reactor model.
    Bernstein H; Yang VC; Langer R
    Biotechnol Bioeng; 1987 Aug; 30(2):239-50. PubMed ID: 18581305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional heparinization via simultaneous separation and reaction in a novel Taylor-Couette flow device.
    Ameer GA; Raghavan S; Sasisekharan R; Harmon W; Cooney CL; Langer R
    Biotechnol Bioeng; 1999 Jun; 63(5):618-24. PubMed ID: 10397818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ex vivo evaluation of a Taylor-Couette flow, immobilized heparinase I device for clinical application.
    Ameer GA; Barabino G; Sasisekharan R; Harmon W; Cooney CL; Langer R
    Proc Natl Acad Sci U S A; 1999 Mar; 96(5):2350-5. PubMed ID: 10051645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracorporeal enzymatic heparin removal: use in a sheep dialysis model.
    Bernstein H; Yang VC; Lund D; Randhawa M; Harmon W; Langer R
    Kidney Int; 1987 Oct; 32(4):452-63. PubMed ID: 3430948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Removal of the anticoagulant activities of the low molecular weight heparin fractions and fragments with flavobacterial heparinase.
    Yang VC; Bernstein H; Cooney CL; Kadam JC; Langer R
    Thromb Res; 1986 Dec; 44(5):599-610. PubMed ID: 3810562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel bioreactor based on suspended particles of agarose-immobilized species.
    Freed LE; Vunjak GV; Drinker PA; Langer R
    ASAIO Trans; 1988; 34(3):732-8. PubMed ID: 3196592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immobilized heparin lyase system for blood deheparinization.
    Bernstein H; Yang VC; Cooney CL; Langer R
    Methods Enzymol; 1988; 137():515-29. PubMed ID: 3374357
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of extracorporeal enzymatic deheparinization on formed blood components.
    Larsen AK; Linhardt RJ; Tapper D; Klein M; Langer R
    Artif Organs; 1984 May; 8(2):198-203. PubMed ID: 6732548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of the intrinsic Michaelis constant of immobilized heparinase.
    Lortie R; Broughton R
    Ann N Y Acad Sci; 1995 Mar; 750():58-61. PubMed ID: 7785881
    [No Abstract]   [Full Text] [Related]  

  • 15. New approaches for anticoagulation in extracorporeal therapy.
    Linhardt RJ; Langer R
    Biomater Artif Cells Artif Organs; 1987; 15(1):91-100. PubMed ID: 2835116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetic and operational study of a cross-flow reactor with immobilized pectolytic enzymes.
    Lozano P; Manjón A; Iborra JL; Cánovas M; Romojaro F
    Enzyme Microb Technol; 1990 Jul; 12(7):499-505. PubMed ID: 1366633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mode of action of heparin lyase on heparin.
    Linhardt RJ; Fitzgerald GL; Cooney CL; Langer R
    Biochim Biophys Acta; 1982 Apr; 702(2):197-203. PubMed ID: 7082675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparinase: in vivo activity and immunogenicity in rabbits.
    Klein MD; Drongowski RA; Linhardt RJ; Cooney CL; Langer RS
    J Lab Clin Med; 1983 Nov; 102(5):828-37. PubMed ID: 6631173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immobilization alters heparin cleaving properties of heparinase I.
    Bhushan I; Alabbas A; Kuberan B; Gupta RB; Desai UR
    Glycobiology; 2017 Nov; 27(11):994-998. PubMed ID: 28973365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of coagulation during cardiopulmonary bypass with a heparinase-modified thromboelastographic assay.
    Tuman KJ; McCarthy RJ; Djuric M; Rizzo V; Ivankovich AD
    J Cardiothorac Vasc Anesth; 1994 Apr; 8(2):144-9. PubMed ID: 8204806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.